BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28845527)

  • 1. Extracellular NAMPT/visfatin causes p53 deacetylation via NAD production and SIRT1 activation in breast cancer cells.
    Behrouzfar K; Alaee M; Nourbakhsh M; Gholinejad Z; Golestani A
    Cell Biochem Funct; 2017 Aug; 35(6):327-333. PubMed ID: 28845527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nampt inhibitor FK866 mimics vitamin B3 deficiency by causing senescence of human fibroblastic Hs68 cells via attenuation of NAD(+)-SIRT1 signaling.
    Song TY; Yeh SL; Hu ML; Chen MY; Yang NC
    Biogerontology; 2015 Dec; 16(6):789-800. PubMed ID: 26330291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring NAD
    Katayoshi T; Nakajo T; Tsuji-Naito K
    J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells.
    Yang NC; Song TY; Chang YZ; Chen MY; Hu ML
    Biogerontology; 2015 Feb; 16(1):31-42. PubMed ID: 25146190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis.
    Reverchon M; Cornuau M; Cloix L; Ramé C; Guerif F; Royère D; Dupont J
    Mol Hum Reprod; 2013 May; 19(5):313-26. PubMed ID: 23315983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
    Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
    J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway.
    Ming GF; Tang YJ; Hu K; Chen Y; Huang WH; Xiao J
    Int J Mol Med; 2016 Aug; 38(2):643-9. PubMed ID: 27277186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VISFATIN (NAMPT) Improves In Vitro IGF1-Induced Steroidogenesis and IGF1 Receptor Signaling Through SIRT1 in Bovine Granulosa Cells.
    Reverchon M; Rame C; Bunel A; Chen W; Froment P; Dupont J
    Biol Reprod; 2016 Mar; 94(3):54. PubMed ID: 26792944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
    Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD
    Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X
    Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors.
    Wang P; Du H; Zhou CC; Song J; Liu X; Cao X; Mehta JL; Shi Y; Su DF; Miao CY
    Cardiovasc Res; 2014 Dec; 104(3):477-88. PubMed ID: 25341895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular visfatin has nicotinamide phosphoribosyltransferase enzymatic activity and is neuroprotective against ischemic injury.
    Zhao Y; Liu XZ; Tian WW; Guan YF; Wang P; Miao CY
    CNS Neurosci Ther; 2014 Jun; 20(6):539-47. PubMed ID: 24750959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells.
    Gholinejad Z; Kheiripour N; Nourbakhsh M; Ilbeigi D; Behroozfar K; Hesari Z; Golestani A; Shabani M; Einollahi N
    Peptides; 2017 Jun; 92():9-15. PubMed ID: 28442350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular visfatin activates gluconeogenesis in HepG2 cells through the classical PKA/CREB-dependent pathway.
    Choi YJ; Choi SE; Ha ES; Kang Y; Han SJ; Kim DJ; Lee KW; Kim HJ
    Horm Metab Res; 2014 Apr; 46(4):233-9. PubMed ID: 24627100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAMPT pathway is involved in the FOXO3a-mediated regulation of GADD45A expression.
    Thakur BK; Lippka Y; Dittrich T; Chandra P; Skokowa J; Welte K
    Biochem Biophys Res Commun; 2012 Apr; 420(4):714-20. PubMed ID: 22430142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors.
    Chini CC; Guerrico AM; Nin V; Camacho-Pereira J; Escande C; Barbosa MT; Chini EN
    Clin Cancer Res; 2014 Jan; 20(1):120-30. PubMed ID: 24025713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.
    Zou XD; Guo SQ; Hu ZW; Li WL
    Mol Med Rep; 2016 May; 13(5):4058-64. PubMed ID: 27035562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.
    Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V
    J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous NAD(+) supplementation protects H9c2 cardiac myoblasts against hypoxia/reoxygenation injury via Sirt1-p53 pathway.
    Liu L; Wang P; Liu X; He D; Liang C; Yu Y
    Fundam Clin Pharmacol; 2014 Apr; 28(2):180-9. PubMed ID: 23384296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.
    Menssen A; Hydbring P; Kapelle K; Vervoorts J; Diebold J; Lüscher B; Larsson LG; Hermeking H
    Proc Natl Acad Sci U S A; 2012 Jan; 109(4):E187-96. PubMed ID: 22190494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.